publicações selecionadas
-
documento
- Preclinical evidence supporting early initiation of citalopram treatment in Machado-Joseph disease: findings in two mouse models 2018
- Citalopram reduces aggregation of ATXN3 in a YAC transgenic mouse model of Machado- Joseph disease 2017
- Transgenic mouse models of Machado-Joseph disease show cerebellar neurochemical profiles similar to that of patients 2017
- Ataxin-3 plays a role in mouse myogenic differentiation through regulation of integrin subunit levels 2010
- Ataxin-3 plays a role in myogenic differentiation through regulation of integrin subunits 2009
- Ataxin-3: a role in the SCF complex? 2009